Non-invasive Blood Pressure Measurement Using Samsung Smartwatch
NCT ID: NCT05302193
Last Updated: 2025-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2021-03-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reliability of Measuring Blood Pressure With a Smartwatch
NCT05401435
Experimental Validation of the Long-term Accuracy of Blood Pressure Measurement Using a Smartwatch
NCT06098092
Smartwatch ABPM vs. Conventional ABPM
NCT04553861
Validation of a Smartwatch for Blood Pressure Monitoring
NCT06627920
Wrist Worn Blood Pressure Measurement
NCT03919136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood pressure and heart rate measurement
Calm measurement of blood pressure and heart rate simultaneously by smartwatch and vital signs monitor. Each participant will undergo this measurement a total of 6 times.
Calm measurement of blood pressure and heart rate (before physical activity)
Simultaneous blood pressure and heart rate measurements at minutes 2 and 5.5 of the experiment.
Physical activity
Five minutes of physical activity, between times 7.5 min and 12.5 min of the experimental part. Riding on a spinning ergometer with a standardized load of 1 W/kg.
Calm measurement of blood pressure and heart rate (after physical activity)
Simultaneous blood pressure and heart rate measurements at times 15.5, 17, 20.5 and 22 minutes of the experimental part.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Calm measurement of blood pressure and heart rate (before physical activity)
Simultaneous blood pressure and heart rate measurements at minutes 2 and 5.5 of the experiment.
Physical activity
Five minutes of physical activity, between times 7.5 min and 12.5 min of the experimental part. Riding on a spinning ergometer with a standardized load of 1 W/kg.
Calm measurement of blood pressure and heart rate (after physical activity)
Simultaneous blood pressure and heart rate measurements at times 15.5, 17, 20.5 and 22 minutes of the experimental part.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnancy
* severe cardiovascular conditions
* severe asthma or other severe respiratory conditions
* diabetes
* hypotension or hypertension
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Czech Technical University in Prague
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veronika Rafl Huttova, MSc
Role: PRINCIPAL_INVESTIGATOR
Czech Technical University in Prague
Jakub Rafl, PhD
Role: PRINCIPAL_INVESTIGATOR
Czech Technical University in Prague
Martin Rozanek, PhD
Role: PRINCIPAL_INVESTIGATOR
Czech Technical University in Prague
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Biomedical Engineering, Czech Technical University in Prague
Kladno, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hahnen C, Freeman CG, Haldar N, Hamati JN, Bard DM, Murali V, Merli GJ, Joseph JI, van Helmond N. Accuracy of Vital Signs Measurements by a Smartwatch and a Portable Health Device: Validation Study. JMIR Mhealth Uhealth. 2020 Feb 12;8(2):e16811. doi: 10.2196/16811.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIBPsmartwatch21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.